Evidence map›Paper›PMID 40299942›Full record

Trial reportPloS one2025

Moderate static magnetic fields prevent estrogen deficiency-induced bone loss: Evidence from ovariectomized mouse model and small sample size randomized controlled clinical trial.

Shenghang Wang, Jiancheng Yang, Yunpeng Wei, Chao Cai, Shuai Chen, Youde Wu, Xiao Li, Lilei Sun, Xianglin Li, Ming Gong and 15 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Shenghang WangDepartment of Spine Surgery, People's Hospital of Longhua, Shenzhen, China.
Jiancheng YangDepartment of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.
Yunpeng WeiShenzhen University of Advanced Technology, Shenzhen, China.
Chao CaiResearch & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, China.
Shuai ChenResearch & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, China.
Youde WuResearch & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, China.
Xiao LiResearch & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, China.
Lilei SunResearch & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, China.
Xianglin LiResearch & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, China.
Ming GongDepartment of Spine Surgery, People's Hospital of Longhua, Shenzhen, China.
Jianhua ZhouDepartment of Spine Surgery, People's Hospital of Longhua, Shenzhen, China.
Yawei HuDepartment of Spine Surgery, People's Hospital of Longhua, Shenzhen, China.
Wang ZhangDepartment of Spine Surgery, People's Hospital of Longhua, Shenzhen, China.
Zengfeng GuoDepartment of Spine Surgery, People's Hospital of Longhua, Shenzhen, China.
Jiacheng LiaoMinle Community Health Service Center, People's Hospital of Longhua, Shenzhen, China.
Chunling LuoMinle Community Health Service Center, People's Hospital of Longhua, Shenzhen, China.
Xiaosu BaiDepartment of Endocrinology, People's Hospital of Longhua, Shenzhen, China.
Xinle LuoDepartment of Spine Surgery, People's Hospital of Longhua, Shenzhen, China.
Liming DuanAn Shi Rui Information Technology Co., Ltd, Shenzhen, China.
Ting HuyanResearch & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, China.
Zhouqi YangResearch & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, China.
Min WeiHeye Health Technology Co., Ltd, Huzhou, China.
Yanwen FangHeye Health Technology Co., Ltd, Huzhou, China.
Hao ZhangDepartment of Spine Surgery, People's Hospital of Longhua, Shenzhen, China.
Peng ShangResearch & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, China.ORCID 0000-0001-5418-6240

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPostmenopausal osteoporosis (PMOP) is the most common type of osteoporosis. Numerous studies have shown that static magnetic fields (SMFs) can inhibit bone loss by regulating bone remodeling. However, there are currently no clinical studies on the treatment of osteoporosis with SMFs. This study aims to investigate the clinical therapeutic effects of moderate static magnetic fields (MMFs) on PMOP.

methodsIn this paper, we constructed MMF device using neodymium-iron-boron (NdFeB) materials. At the animal level, the effect of MMF exposure for 8 weeks on estrogen deficiency-induced bone loss was investigated by evaluating bone microstructure, mechanical properties, and bone conversion using ovariectomized (OVX) mice. Clinically, a single-blind randomized controlled study in patients with PMOP was designed. PMOP patients aged 55-70 years were recruited and randomized into the control and MMF treatment groups. Clinical assessments of bone mineral density (BMD), bone turnover markers (BTMs) and VAS scores were performed at baseline and day 90, respectively.

resultsThe results showed that MMF exposure significantly improved BMD, bone mineral content (BMC), bone microarchitecture and bone strength in OVX mice. For bone turnover, MMF increased the number of osteoblasts on the bone surface of OVX mice as well as the level of serum bone formation marker P1NP, while decreasing the number of osteoclasts and the level of serum bone resorption marker β-CTX. The clinical trial's results showed that MMF treatment had a positive effect on the improvement of BMD in the lumbar spine and increased serum P1NP levels while decreased β-CTX levels. In addition, MMF treatment decreased participants' VAS scores for low back pain.

conclusionsThe results of both animal and clinical studies demonstrated that MMF treatment improved bone turnover and have a positive effect on BMD improvement, as well as alleviated low back pain in PMOP patients. This study will promote the translational research and clinical application of SMF treatment for osteoporosis.

trial registrationIntervention study of moderate static magnetic field on osteoporosis and iron metabolism in postmenopausal women, ChiCTR2100048604.

Indexed as

Bone ResorptionEstrogensMagnetic FieldsMagnetic Field TherapyOsteoporosis, PostmenopausalAgedAnimalsBone DensityBone RemodelingDisease Models, AnimalFemaleHumansMiceMiddle AgedOvariectomySingle-Blind MethodEstrogens

Identifiers

PMID40299942
PMCPMC12040201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.